Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 74 results.
User Information
Export Records
  1. 1.   A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor
  2. Huang, Yongjian; Ognjenovic,Jana; Karandur, Deepti; Miller, Kate; Merk,Alan; Subramaniam, Sriram; Kuriyan, John
  3. eLife. 2021, Nov 30; 10
  1. 2.   Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite
  2. Emidio, Nayara Braga; Meli, Rajeshwari; Tran, Hue N. T.; Baik, Hayeon; Morisset-Lopez, Severine; Elliott, Alysha G.; Blaskovich, Mark A. T.; Spiller, Sabrina; Beck-Sickinger, Annette G.; Schroeder,Christina; Muttenthaler, Markus
  3. JOURNAL OF MEDICINAL CHEMISTRY. 2021, Jul 8; 64(13): 9484-9495.
  1. 3.   Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
  2. Gillies, Taryn E; Pargett, Michael; Silva, Jillian M; Teragawa, Carolyn K; McCormick, Frank; Albeck, John G
  3. Molecular systems biology. 2020, Oct; 16(10): e9518.
  1. 4.   Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart
  2. Hwang, C. J.; Fields, J. R.; Shiao, Y. H.
  3. Cell Death & Disease. 2011, Dec; 2
  1. 5.   Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
  2. Tsai, Y. C.; Weissman, A. M.
  3. Febs Letters. 2011, Oct; 585(20): 3166-3173.
  1. 6.   Dysregulated Delta Np63 alpha Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes
  2. Ha, L. A.; Ponnamperuma, R. M.; Jay, S.; Ricci, M. S.; Weinberg, W. C.
  3. Plos One. 2011, Jul; 6(7): 13.
  1. 7.   Normalization of Proliferation and Tight Junction Formation in Bladder Epithelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome by d-Proline and d-Pipecolic Acid Derivatives of Antiproliferative Factor
  2. Keay, S.; Kaczmarek, P.; Zhang, C. O.; Koch, K.; Szekely, Z.; Barchi, J. J.; Michejda, C.
  3. Chemical Biology & Drug Design. 2011, Jun; 77(6): 421-430.
  1. 8.   HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
  2. McCormack, M.; Alfirevic, A.; Bourgeois, S.; Farrell, J. J.; Kasperaviciute, D.; Carrington, M.; Sills, G. J.; Marson, T.; Jia, X. M.; de Bakker, P. I. W.; Chinthapalli, K.; Molokhia, M.; Johnson, M. R.; O'Connor, G. D.; Chaila, E.; Alhusaini, S.; Shianna, K. V.; Radtke, R. A.; Heinzen, E. L.; Walley, N.; Pandolfo, M.; Pichler, W.; Park, B. K.; Depondt, C.; Sisodiya, S. M.; Goldstein, D. B.; Deloukas, P.; Delanty, N.; Cavalleri, G. L.; Pirmohamed, M.
  3. New England Journal of Medicine. 2011, Mar; 364(12): 1134-1143.
  1. 9.   CEBPD Reverses RB/E2F1-Mediated Gene Repression and Participates in HMDB-Induced Apoptosis of Cancer Cells
  2. Pan, Y. C.; Li, C. F.; Ko, C. Y.; Pan, M. H.; Chen, P. J.; Tseng, J. T.; Wu, W. C.; Chang, W. C.; Huang, A. M.; Sterneck, E.; Wang, J. M.
  3. Clinical Cancer Research. 2010, Dec; 16(23): 5770-5780.
  1. 10.   Lsh participates in DNA methylation and silencing of stem cell genes
  2. Xi, S.; Geiman, T. M.; Briones, V.; Guang Tao, Y.; Xu, H.; Muegge, K.
  3. Stem Cells. 2009, Nov; 27(11): 2691-702.
  1. 11.   Constitutive expression of human keratin 14 gene in mouse lung induces premalignant lesions and squamous differentiation
  2. Dakir, E.; Feigenbaum, L.; Linnoila, R. I.
  3. Carcinogenesis. 2008 29(12): 2377-2384.
  1. 12.   Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
  2. Wei, Q.; Jiang, H.; Matthews, C. P.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(50): 19738-19743.
  1. 13.   EphrinB1 signals from the cell surface to the nucleus by recruitment of STAT3
  2. Bong, Y. S.; Lee, H. S.; Carim-Todd, L.; Mood, K.; Nishanian, T. G.; Tessarollo, L.; Daar, I. O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Oct; 104(44): 17305-17310.
  1. 14.   A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors
  2. Chen, J. H.; Yao, X. H.; Gong, W.; Hu, J.; Zhou, X. D.; Chen, K.; Liu, H.; Ping, Y. F.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Sep; 84(3): 223-231.
  1. 15.   Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; An, P.; Kim, H. J.; Huang, J. Q.; Clarke, R.; Osborne, C. K.; Inman, J. K.; Appella, E.; Farrar, W. L.
  3. Cancer Cell. 2006, Dec; 10(6): 487-499.
  1. 16.   Ectodysplasin regulates the lymphotoxin-beta pathway for hair differentiation
  2. Cui, C. Y.; Hashimoto, T.; Grivennikov, S. I.; Piao, Y. L.; Nedospasov, S. A.; Schiessinger, D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, Jun; 103(24): 9142-9147.
  1. 17.   Purification, crystallization and preliminary X-ray diffraction of human S100A15
  2. Boeshans, K. M.; Wolf, R.; Voscopoulos, C.; Gillette, W.; Esposito, D.; Mueser, T. C.; Yuspa, S. H.; Ahvazi, B.
  3. Acta Crystallographica Section F-Structural Biology and Crystallization Communications. 2006, May; 62: 467-470.
  1. 18.   Topotecan blocks hypoxia-inducible factor-1 alpha, and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells
  2. Beppu, Y.; Nakamura, K.; Linehan, W. M.; Rapisarda, A.; Thiele, C. J.
  3. Cancer Research. 2005, JUN 1; 65(11): 4775-4781.
  1. 19.   A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells
  2. Weber, T. J.; Siegel, R. W.; Markille, L. M.; Chrisler, W. B.; Lei, X. Y. C.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, MAY; 43(1): 31-37.
  1. 20.   p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase
  2. Zhao, Y. F.; Chaiswing, L.; Velez, J. M.; Batinic-Haberle, I.; Colburn, N. H.; Oberley, T. D.; St Clair, D. K.
  3. Cancer Research. 2005, MAY 1; 65(9): 3745-3750.
  1. 21.   Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1
  2. Tao, Y. G.; Xing, S.; Deng, X. Y.; Xie, D. X.; Lee, L. M.; Liu, Y. P.; Wei, L.; Li, L. L.; Lin, D.; Qiao, W.; Gong, J. P.; Ya, C.
  3. Experimental Cell Research. 2005, FEB 15; 303(2): 240-251.
  1. 22.   Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
  2. Sun, R. H.; Gao, P.; Chen, L.; Ma, D. L.; Wang, J. M.; Oppenheim, J. J.; Zhang, N.
  3. Cancer Research. 2005, FEB 15; 65(4): 1433-1441.
  1. 23.   Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo
  2. Cataisson, C.; Pearson, A. J.; Torgerson, S.; Nedospasov, S. A.; Yuspa, S. H.
  3. Journal of Immunology. 2005, FEB 1; 174(3): 1686-1692.
  1. 24.   Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappa B activation and transformation in resistant JB6 cells
  2. Hu, J.; Nakano, H.; Sakurai, H.; Colburn, N. H.
  3. Carcinogenesis. 2004, OCT; 25(10): 1991-2003.
  1. 25.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel